ADVFN
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

2.46
-0.06
( -2.38% )

Maravai LifeSciences Holdings Inc (MRVI) Quote

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
2.46
( -2.38% )
Bid
2.46
Ask
2.47
Volume
492,351
2.45 Day's Range 2.60
1.665 52 Week Range 10.03
Market Cap
Previous Close
2.52
Open
2.53
Last Trade
64
@
2.465
Last Trade Time
12:29:18
Financial Volume
$ 1,241,231
VWAP
2.521
Average Volume (3m)
1,789,529
Shares Outstanding
254,659,517
Dividend Yield
-
PE Ratio
-4.36
Earnings Per Share (EPS)
-0.57
Revenue
262.4M
Net Profit
-144.85M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was $2.52. Over the last year, Maravai LifeSciences shares have traded in a share price range of $ 1.665 to $ 10.03.

Maravai LifeSciences currently has 254,659,517 shares outstanding. The market capitalization of Maravai LifeSciences is $641.74 million. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -4.36.

MRVI Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.28-10.21897810222.742.932.4516499262.69225356CS
40.4321.18226600992.032.932.0120876592.5039048CS
120.3516.58767772512.112.931.9517895292.2770459CS
26-2.14-46.52173913044.66.051.66526056862.79480929CS
52-6.76-73.31887201749.2210.031.66522670184.76519085CS
156-22.6-90.183559457325.0627.881.66522237429.23214341CS
260-28.65-92.092574734831.1163.551.665199202116.98000134CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences share price?
The current share price of Maravai LifeSciences is $ 2.46
How many Maravai LifeSciences shares are in issue?
Maravai LifeSciences has 254,659,517 shares in issue
What is the market cap of Maravai LifeSciences?
The market capitalisation of Maravai LifeSciences is USD 641.74M
What is the 1 year trading range for Maravai LifeSciences share price?
Maravai LifeSciences has traded in the range of $ 1.665 to $ 10.03 during the past year
What is the PE ratio of Maravai LifeSciences?
The price to earnings ratio of Maravai LifeSciences is -4.36
What is the cash to sales ratio of Maravai LifeSciences?
The cash to sales ratio of Maravai LifeSciences is 2.41
What is the reporting currency for Maravai LifeSciences?
Maravai LifeSciences reports financial results in USD
What is the latest annual turnover for Maravai LifeSciences?
The latest annual turnover of Maravai LifeSciences is USD 262.4M
What is the latest annual profit for Maravai LifeSciences?
The latest annual profit of Maravai LifeSciences is USD -144.85M
What is the registered address of Maravai LifeSciences?
The registered address for Maravai LifeSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Maravai LifeSciences operate in?
Maravai LifeSciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NEXMNexMetals Mining Corporation
$ 7.2467
(204.48%)
201.63k
VLCNVolcon Inc
$ 27.3222
(196.20%)
24.92M
ABVEAbove Food Ingredients Inc
$ 3.31
(97.02%)
140.42M
LCDLGraniteShares 2X Long LCID Daily ETF
$ 37.89
(74.94%)
1.11M
BTOGBit Origin Ltd
$ 0.550799
(66.00%)
151.56M
GLIBAGCI Liberty Inc Series C GCI Group
$ 34.52
(-62.37%)
141.88k
PTNMPitanium Ltd
$ 7.2496
(-45.94%)
1.83M
YHCLQR House Inc
$ 6.23
(-41.94%)
6.5M
CDNACareDx Inc
$ 11.57
(-39.74%)
9.4M
ZVSAZyVersa Therapeutics Inc
$ 0.2001
(-35.72%)
1.44M
LCIDLucid Group Inc
$ 3.155
(37.77%)
726.41M
OPENOpendoor Technologies Inc
$ 1.6395
(10.03%)
382.68M
BTOGBit Origin Ltd
$ 0.5512
(66.12%)
151.57M
ABVEAbove Food Ingredients Inc
$ 3.3001
(96.43%)
140.43M
WINTWindtree Therapeutics Inc
$ 1.165
(29.44%)
109.13M

MRVI Discussion

View Posts
Monksdream Monksdream 1 year ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 1 year ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

Delayed Upgrade Clock